Australia mRNA Therapeutics Market Size and Forecast to 2035 by Application and Disease Indication | 19% CAGR Drives USD 1.78 Billion Opportunity Across Influenza and RSV
Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personalized medicine Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personal…
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Cancele cuando quiera · 99 CA$/mes


